Dr James Campbell studied applied biology at the University of the West of England and went on to receive a PhD for a study of the utilization of glycoprotein substrates by grampositive pathogenic bacteria. James then joined a proteomics research company focusing on biomarker discovery and the development of quantitative mass spectrometry methods, before moving to The Institute of Cancer Research, London. Since then, James has worked with the next generation sequencing facility and helped set up the bioinformatic analysis pipelines for the Tumour Profiling Unit. He currently leads the Bioinformatics Facility of the ICR's Cancer Research UK Centre, supporting research groups across the institute. Lorenza Giannella (Training Manager, Biochemical Society) spoke to him about his work.

This content is only available as a PDF.